The Influence of miRNAs on Radiotherapy Treatment in Prostate Cancer – A Systematic Review

Bibliographic Details
Title: The Influence of miRNAs on Radiotherapy Treatment in Prostate Cancer – A Systematic Review
Authors: Sílvia Soares, Susana G. Guerreiro, Natália Cruz-Martins, Isabel Faria, Pilar Baylina, Maria Goreti Sales, Miguel A. Correa-Duarte, Rúben Fernandes
Source: Frontiers in Oncology, Vol 11 (2021)
Publisher Information: Frontiers Media S.A., 2021.
Publication Year: 2021
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: prostate cancer, radiotherapy, RNA therapy, microRNA, oncomiR, oncosupressor miR, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: In the last years, extensive investigation on miRNomics have shown to have great advantages in cancer personalized medicine regarding diagnosis, treatment and even clinical outcomes. Prostate cancer (PCa) is the second most common male cancer and about 50% of all PCa patients received radiotherapy (RT), despite some of them develop radioresistance. Here, we aim to provide an overview on the mechanisms of miRNA biogenesis and to discuss the functional impact of miRNAs on PCa under radiation response. As main findings, 23 miRNAs were already identified as being involved in genetic regulation of PCa cell response to RT. The mechanisms of radioresistance are still poorly understood, despite it has been suggested that miRNAs play an important role in cell signaling pathways. Identification of miRNAs panel can be thus considered an upcoming and potentially useful strategy in PCa diagnosis, given that radioresistance biomarkers, in both prognosis and therapy still remains a challenge.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2234-943X
Relation: https://www.frontiersin.org/articles/10.3389/fonc.2021.704664/full; https://doaj.org/toc/2234-943X
DOI: 10.3389/fonc.2021.704664
Access URL: https://doaj.org/article/95ae17263bf549938bbdf9ebfe0710ed
Accession Number: edsdoj.95ae17263bf549938bbdf9ebfe0710ed
Database: Directory of Open Access Journals
More Details
ISSN:2234943X
DOI:10.3389/fonc.2021.704664
Published in:Frontiers in Oncology
Language:English